Clinical studies of p53 in treatment and benefit of breast cancer patients.

作者: J Bergh

DOI: 10.1677/ERC.0.0060051

关键词:

摘要: This article describes p53 as a prognostic and predictive factor, together with some information on how best to determine the status. By December 1998, 13,000 articles were identified Pub Med, National Library of Medicine. Within one week further 62 recorded making it difficult give complete story. review will focus discussing in relation its potential. So far, no firm conclusions can be made based studied. may be, part, because many studies have used less than optimal techniques for determination status, fact that lacked power detect potential difference outcome from specific therapy

参考文章(67)
Sigrid Sjögren, Prognostic factors with predictive potential in breast cancer : special focus on the tumour suppressor p53 [Uppsala University] , Distributor, Almqvist & Wiksell International. ,(1997)
D S Hawkins, G W Demers, D A Galloway, Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Research. ,vol. 56, pp. 892- 898 ,(1996)
Kurt W. Kohn, Joany Jackman, Ian Magrath, Kishor Bhatia, Daniel Jondle, Patrick M. O'Connor, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines Cancer Research. ,vol. 53, pp. 4776- 4780 ,(1993)
Alessandra Faranda, Umberto Veronesi, Bruno Salvadori, Maria Grazia Daidone, Rosella Silvestrini, Elvira Benini, Patrizia Boracchi, Gorana Tomasic, Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers. Clinical Cancer Research. ,vol. 2, pp. 2007- 2013 ,(1996)
Cecilia Williams, Torbjörn Norberg, Afshin Ahmadian, Fredrik Pontén, Jonas Bergh, Mats Inganäs, Joakim Lundeberg, Mathias Uhlén, Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets Clinical Chemistry. ,vol. 44, pp. 455- 462 ,(1998) , 10.1093/CLINCHEM/44.3.455
Christine A. Jost, Maria C. Marin, William G. Kaelin Jr, p73 is a human p53-related protein that can induce apoptosis Nature. ,vol. 389, pp. 191- 194 ,(1997) , 10.1038/38298
T Jansson, M Inganäs, S Sjögren, T Norberg, A Lindgren, L Holmberg, J Bergh, p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings. Journal of Clinical Oncology. ,vol. 13, pp. 2745- 2751 ,(1995) , 10.1200/JCO.1995.13.11.2745
R M Elledge, S Green, L Howes, G M Clark, M Berardo, D C Allred, R Pugh, D Ciocca, P Ravdin, J O'Sullivan, S Rivkin, S Martino, C K Osborne, bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. Journal of Clinical Oncology. ,vol. 15, pp. 1916- 1922 ,(1997) , 10.1200/JCO.1997.15.5.1916
G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga, Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients. International Journal of Oncology. ,vol. 12, pp. 1117- 1125 ,(1998) , 10.3892/IJO.12.5.1117
R. Callahan, p53 mutations, another breast cancer prognostic factor. Journal of the National Cancer Institute. ,vol. 84, pp. 826- 827 ,(1992) , 10.1093/JNCI/84.11.826